
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/16/2025 | Q3 | -- | -- | -- | -$0.23 | -- |
04/30/2025 | Q2 | -- | -- | -- | -$0.15 | -- |
03/17/2025 | Q1 | -- | -- | -$0.54 | -$0.20 | -$0.34 |
12/16/2024 | Q4 | -- | -- | -$0.20 | -$0.23 | $0.03 |
09/16/2024 | Q3 | -- | -- | -$0.40 | -- | -- |
04/30/2024 | Q2 | -- | -- | -$0.22 | -$0.32 | $0.10 |
03/18/2024 | Q1 | -- | -- | -$0.18 | -$0.27 | $0.09 |
12/15/2023 | Q4 | -- | -- | -$0.03 | -- | -- |
09/14/2023 | Q3 | -- | -- | -$0.31 | -- | -- |
04/30/2023 | Q2 | -- | -- | -$0.21 | -$0.25 | $0.04 |
03/17/2023 | Q1 | -- | -- | -$0.23 | -$0.32 | $0.09 |
12/15/2022 | Q4 | -- | -- | -$0.23 | -$0.30 | $0.07 |
09/14/2022 | Q3 | -- | -- | -$0.23 | -- | -- |
04/30/2022 | Q2 | -- | -- | -$0.20 | -- | -- |
03/17/2022 | Q1 | -- | -- | -$0.61 | -$0.44 | -$0.17 |
12/14/2021 | Q4 | -- | -- | -$0.61 | -$0.49 | -$0.12 |
09/14/2021 | Q3 | -- | -- | -$0.50 | -- | -- |
07/12/2021 | Q2 | -- | -- | -$0.02 | -$0.41 | $0.39 |
03/17/2021 | Q1 | -- | -- | -$0.67 | -$0.47 | -$0.20 |
12/14/2020 | Q4 | -- | -- | -$2.93 | -- | -- |
09/11/2020 | Q3 | -- | -- | -$0.33 | -- | -- |
04/30/2020 | Q2 | -- | -- | -$0.24 | -- | -- |
01/31/2020 | Q1 | -- | -- | -$0.40 | -- | -- |
10/31/2019 | Q4 | -- | -- | -$1.00 | -- | -- |
07/31/2019 | Q3 | -- | -- | -$1.70 | -- | -- |
04/30/2019 | Q2 | -- | -- | -$0.76 | -- | -- |
01/31/2019 | Q1 | -- | -- | -$1.10 | -- | -- |
10/31/2018 | Q4 | -- | -- | -$1.70 | -$0.70 | -$1.00 |
07/31/2018 | Q3 | -- | -- | -$0.80 | -$0.70 | -$0.10 |
04/30/2018 | Q2 | -- | -- | -$1.10 | -- | -- |
01/31/2018 | Q1 | -- | -- | -$1.20 | -- | -- |
10/31/2017 | Q4 | -- | -- | -$1.10 | -- | -- |
07/31/2017 | Q3 | -- | -- | -$10.00 | -- | -- |
04/30/2017 | Q2 | -- | -- | -$0.40 | -- | -- |
01/31/2017 | Q1 | -- | -- | -$1.60 | -- | -- |
10/31/2016 | Q4 | -- | -- | -$1.40 | -- | -- |
09/15/2016 | Q3 | -- | -- | -$15.60 | -- | -- |
07/29/2016 | Q2 | -- | -- | -$50.40 | -- | -- |
03/16/2016 | Q1 | -- | -- | -$12.80 | -- | -- |
12/16/2015 | Q4 | -- | -- | -$1.20 | -- | -- |
08/10/2015 | Q3 | -- | -- | -$7.60 | -- | -- |
U.S. Gold reported -- worth of top line sales in its most recent quarter.
U.S. Gold announced earnings per share of -$0.54 which represents a miss of analyst forecast a -$0.20 per share.
U.S. Gold reported -- that represents -- per share over the last quarter.
U.S. Gold's earnings are forecast to decrease from -$0.74 per share to -$1.30 per share next year representing a decrease of -6.31%.
U.S. Gold's next earnings date is September 16, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.